Home / Brands / Generic Peptides / Generic Peptides AICAR 50 mg and 100 mg Research Grade Vials
Generic Peptides AICAR 50 mg and 100 mg Research Grade Vials
Generic Peptides AICAR 50 mg and 100 mg Research Grade Vials
Generic Peptides

Generic Peptides AICAR 50 mg and 100 mg Research Grade Vials

Injection · 50 mg · vial

Out of stock
$45.00

Generic Peptides AICAR is acadesine, an AMPK activator from the nucleoside family supplied as a lyophilized research powder in two vial sizes: 50 mg and 100 mg.

GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. AICAR for sale with fast international shipping and dispatch within two business days after payment.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides AICAR - 50 mg and 100 mg Vials

Generic Peptides AICAR is acadesine, an AMPK activator sold as a lyophilized research powder in 50 mg and 100 mg vials. It sits in this line because of the metabolic work it is used in, but chemically it is a nucleoside analog and not a peptide: its formula is C9H14N4O5 and its mass is about 258 g/mol. It is normally read next to another small metabolic molecule such as NAD+.

  • Two vial sizes - 50 mg and 100 mg
  • Nucleoside analog - not a peptide
  • Lyophilized powder - needs a solvent
  • GMP-made, HPLC-verified, COA on file

Variant Comparison

Both vials hold the same compound, so the choice is how much material one series needs.

Variant Dosage Form and quantity Best use
AICAR 50 mg 50 mg Lyophilized vial Short runs
AICAR 100 mg 100 mg Lyophilized vial Extended series

The 100 mg vial carries twice the material of the 50 mg vial, and both are international only, with no U.S. domestic option on this page. A lipolysis fragment such as AOD 9604 is a common companion arm when fat metabolism is the read-out, while a glucose handling agent such as Semaglutide is kept in a separate group.

How AICAR Works

Cells take the compound up and convert it into ZMP, which mimics the effect of AMP and activates AMP-activated protein kinase. In skeletal muscle models that switch stimulates glucose uptake and p38 MAPK activity, and rodent work reports better endurance that appears to come from a shift of fast fibres towards an oxidative type; there is no human fibre type data. Human plasma half-life is about one hour. It is not approved, and the human cardiac programme stopped at the end of 2010.

Reconstitution & Storage

The powder is dissolved with sterile or bacteriostatic water, which is not in the pack, added down the vial wall and swirled rather than shaken. Divide the amount on the label by the millilitres added: 50 mg in 5 mL gives 10 mg per mL. Keep the lyophilized vial at 2-8 C, protected from light, and the mixed solution at 2-8 C for about four weeks.

Dosage & Administration

No human dose is stated here and the vial is not a medicine. AICAR has no approved indication and no validated human dose, so nothing on this page is a dosing guide. Scientific work on this compound has been reported in body weight terms rather than in a fixed milligram dose. Activators of AMPK are named in WADA class S4 and are banned in sport at all times.

Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use. AICAR is supplied as a lyophilized powder and stays stable when the vial is kept cold and dry.

Specifications

Trade NameAICAR
Generic NameAcadesine (AICA-riboside)
ManufacturerGeneric Peptides
Dosage50 mg or 100 mg per vial
PackageLyophilized powder, one vial
Drug ClassNucleoside analog; AMPK activator
AdministrationSubcutaneous (research protocols)
StorageLyophilized 2-8 C; mixed 2-8 C, 4 weeks
Prescription StatusResearch use only
VerificationBatch details confirmed with supplier
ShippingInternational, about USD 35; no USA option

Stacks

Two Metabolic Inputs

AICAR as the AMPK arm and NAD+ as the coenzyme arm, held in separate groups so an energy sensing signal is not read together with a redox signal.

Expected outcome: a layout that separates two metabolic markers in one experiment.

AMPK Arm And Lipolysis Arm

AICAR beside AOD 9604, one acting through AMPK and the other through beta-3 adrenergic signalling, with fat metabolism read as a laboratory marker rather than an endpoint of use.

Expected outcome: a comparison of two different routes into fat metabolism.

Glucose Handling Comparison

AICAR as the intracellular route and Semaglutide as the receptor route, run apart with glucose as a laboratory read-out in both arms.

Expected outcome: a view of how two unrelated mechanisms touch the same glucose marker.

For laboratory research only. Consult a healthcare professional before handling any compound. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

AICAR is the short name of acadesine, also written AICA-riboside, a small molecule that activates AMP-activated protein kinase. Its formula is C9H14N4O5, its mass is about 258 g/mol, its CAS number is 2627-69-2 and its ATC code is C01EB13. It was studied as a cardioprotective agent and in acute lymphoblastic leukaemia, and the human cardiac programme was stopped at the end of 2010.

No. AICAR is a nucleoside analog, which means it is built from a sugar and a heterocyclic base rather than from a chain of amino acids. It is sold in the same catalogue as research peptides because of the metabolic work it is used in, and its page sits in this line, but the compound itself has no peptide bond. That difference matters when a laboratory protocol is planned.

The compound enters the cell and is converted into ZMP, a nucleotide that mimics the effect of AMP on AMP-activated protein kinase and switches the enzyme on without any change in cellular energy charge. Downstream, skeletal muscle models show increased glucose uptake and p38 MAPK activity, and rodent studies report better endurance that seems to follow a shift of fast fibres towards an oxidative type.

Sterile or bacteriostatic water is added down the wall of the vial and the contents are swirled, not shaken; the solvent is not in the pack. Concentration is the amount on the label divided by the millilitres added, so 50 mg in 5 mL gives 10 mg per mL. The lyophilized vial is kept at 2-8 C, protected from light, and the mixed solution at 2-8 C for about four weeks.

No validated human safety profile exists for AICAR, because the cardiac programme was halted and no approved product followed. Reported items in the clinical literature include effects on glucose metabolism, which are expected of an AMPK activator, and bradycardia with haemodynamic changes in the cardiac setting. Injection site reactions are the common local effect in the injection class. Long term effects are not characterised, and the human dose is not established.

Yes. Activators of AMP-activated protein kinase are named in class S4, hormone and metabolic modulators, of the WADA Prohibited List, and acadesine has been on that list since 2009. Substances in that class are prohibited at all times, in and out of competition. In 2009 the BMJ reported traces of the compound in the blood of cyclists at the Tour de France, which is part of why the class was written.

Yes, both vial sizes are in stock on this page and can be ordered directly. The 50 mg and 100 mg vials ship internationally and there is no U.S. domestic option for this product. International shipping is about USD 35, orders are processed in one to two business days and transit runs four to ten days depending on the destination country.

No reviews yet

Be the first to share your experience with Generic Peptides AICAR 50 mg and 100 mg Research Grade Vials

Log in to write a review

Complete the cycle

Stack it with

View all